Literature DB >> 33839775

Intensive and app-delivered occupational therapy to improve upper extremity function in early diffuse cutaneous systemic sclerosis: a pilot two-arm trial.

Susan L Murphy1,2, Mary Barber1, Suiyuan Huang3, Maya Sabbagh4, Gary Cutter5, Dinesh Khanna3.   

Abstract

OBJECTIVE: SSc reduces upper extremity function and performance of everyday activities; however, there are few evidence-based rehabilitation interventions. This study examined short and longer-term effects of two occupational therapy interventions on hand disability.
METHODS: Participants with diffuse cutaneous SSc were randomized to one of two 18-week interventions: Intensive group, receiving eight weekly in-person occupational therapy sessions with App-delivered home exercises, or App Alone group. The primary outcome was QuickDASH hand disability; secondary outcomes were physical function (PROMIS scale), and total active hand motion. Linear mixed models were used to examine treatment effects.
RESULTS: Most participants were female (72%); the mean age was 52 years (13.4) (n = 32). There were no significant between-group effects on QuickDASH (P = 1.0; mean change -6.4 on 0-100 scale in both groups at 18 weeks). Left lateral pinch, an exploratory outcome, improved in App Alone compared with Intensive from baseline to 18 weeks. Within groups, the Intensive group had the largest improvements after 8 weeks (-8.5 on QuickDASH; P = 0.03), but then lost gains from 8 to 18 weeks while the App Alone group had modest improvements from baseline to 8 weeks, but then continued to improve. Of completers, 50% had clinically meaningful improvement on QuickDASH in the Intensive group and 64% had improvement in App Alone.
CONCLUSION: Both interventions showed beneficial effects on hand disability. Participants in the App Alone group improved equally to the Intensive group at 18 weeks. Our findings provide support for further study into telehealth rehabilitation approaches. TRIAL REGISTRATION: NCT03482219.
© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  hand; occupational therapy; quality of life; rehabilitation; scleroderma and related disorders

Mesh:

Year:  2021        PMID: 33839775      PMCID: PMC8566263          DOI: 10.1093/rheumatology/keab339

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  29 in total

1.  Adult norms for a commercially available Nine Hole Peg Test for finger dexterity.

Authors:  Kimatha Oxford Grice; Kimberly A Vogel; Viet Le; Ana Mitchell; Sonia Muniz; Mary Ann Vollmer
Journal:  Am J Occup Ther       Date:  2003 Sep-Oct

2.  Impact of hand and face disabilities on global disability and quality of life in systemic sclerosis patients.

Authors:  S Maddali-Bongi; A Del Rosso; S Mikhaylova; B Francini; A Branchi; M Baccini; M Matucci-Cerinic
Journal:  Clin Exp Rheumatol       Date:  2014-05-21       Impact factor: 4.473

3.  Reliability and validity of grip and pinch strength evaluations.

Authors:  V Mathiowetz; K Weber; G Volland; N Kashman
Journal:  J Hand Surg Am       Date:  1984-03       Impact factor: 2.230

4.  Personalized Physical Therapy Versus Usual Care for Patients With Systemic Sclerosis: A Randomized Controlled Trial.

Authors:  François Rannou; Isabelle Boutron; Luc Mouthon; Katherine Sanchez; Vincent Tiffreau; Eric Hachulla; Philipe Thoumie; Jean Cabane; Emmanuel Chatelus; Jean Sibilia; Alexandra Roren; Alice Berezne; Gabriel Baron; Raphael Porcher; Loic Guillevin; Philippe Ravaud; Serge Poiraudeau
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-06-07       Impact factor: 4.794

Review 5.  Musculoskeletal rehabilitation in the person with scleroderma.

Authors:  Janet L Poole
Journal:  Curr Opin Rheumatol       Date:  2010-03       Impact factor: 5.006

6.  Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies.

Authors:  P J Clements; P A Lachenbruch; J R Seibold; B Zee; V D Steen; P Brennan; A J Silman; N Allegar; J Varga; M Massa
Journal:  J Rheumatol       Date:  1993-11       Impact factor: 4.666

7.  Occupational Therapy Treatment to Improve Upper Extremity Function in Individuals with Early Systemic Sclerosis: A Pilot Study.

Authors:  Susan L Murphy; Mary Whitehouse Barber; Kate Homer; Carole Dodge; Gary R Cutter; Dinesh Khanna
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-11       Impact factor: 4.794

8.  Efficacy of a tailored rehabilitation program for systemic sclerosis.

Authors:  S Maddali Bongi; A Del Rosso; F Galluccio; G Tai; F Sigismondi; M Passalacqua; G Landi; M Baccini; M L Conforti; I Miniati; M Matucci-Cerinic
Journal:  Clin Exp Rheumatol       Date:  2009 May-Jun       Impact factor: 4.473

9.  The evaluation of a home-based program for hands in patients with systemic sclerosis.

Authors:  Sibila Floriano Landim; Manoel Barros Bertolo; Marcos Felipe Marcatto de Abreu; Ana Paula Del Rio; Cecilia Carmen Mazon; João Francisco Marques-Neto; Janet L Poole; Eduardo de Paiva Magalhães
Journal:  J Hand Ther       Date:  2017-12-01       Impact factor: 1.950

10.  A tutorial on pilot studies: the what, why and how.

Authors:  Lehana Thabane; Jinhui Ma; Rong Chu; Ji Cheng; Afisi Ismaila; Lorena P Rios; Reid Robson; Marroon Thabane; Lora Giangregorio; Charles H Goldsmith
Journal:  BMC Med Res Methodol       Date:  2010-01-06       Impact factor: 4.615

View more
  2 in total

1.  Rehabilitation Interventions in Systemic Sclerosis: A Systematic Review and Future Directions.

Authors:  Susan L Murphy; Janet L Poole; Yen T Chen; Alain Lescoat; Dinesh Khanna
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-12-22       Impact factor: 5.178

Review 2.  Skin involvement in early diffuse cutaneous systemic sclerosis: an unmet clinical need.

Authors:  Ariane L Herrick; Shervin Assassi; Christopher P Denton
Journal:  Nat Rev Rheumatol       Date:  2022-03-15       Impact factor: 32.286

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.